Insights from 2024 WCLC


 

WCLC 2024 Insights: PACIFIC-BRAZIL Study - Intensified Chemo-Immuno-Radiotherapy With Durvalumab for Stage III NSCLC

39 views
September 23, 2024
Comments 0
Login to view comments. Click here to Login